Clarus Therapeutics

About:

Clarus Therapeutics is a biopharmaceutical company that develops androgen-based medicines for men and women.

Website: http://www.clarustherapeutics.com

Top Investors: H.I.G. Capital, Armentum Partners, C-Bridge Capital, Thomas, McNerney & Partners

Description:

Clarus Therapeutics is a biopharmaceutical company that develops androgen-based medicines for men and women. It offers OriTex, a proprietary oral testosterone product for use in men with low testosterone levels.

Total Funding Amount:

$122M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Northbrook, Illinois, United States

Founded Date:

2003-01-01

Contact Email:

admin(AT)clarustherapeutics.com

Founders:

Robert E. Dudley

Number of Employees:

11-50

Last Funding Date:

2022-04-25

IPO Status:

Public

Industries: